FDA Approved: LINEZOLID — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Linezolid submitted by Hospira, Inc. under NDA206473.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections
• Hospital-acquired Pneumonia
• Methicillin-resistant Staphylococcus Aureus Infections
• Pneumonia
• Vancomycin-resistant Enterococcus Infections

Drugs mentioned

• Linezolid (Linezolid)

Snippet

SUPPL AP for LINEZOLID (LINEZOLID)